Where Tech Meets BioTech

We are excited to launch another high energy, action filled, synthetic biology conference this year in San Francisco. At SynBioBeta SF 2015, you’ll meet attendees from around the globe, learn best practices, and hear from industry thought leaders, investors, and entrepreneurs about the ever changing landscape of synthetic biology.

Join us for conversations on sector-specific progress ranging from research-enabling tools to low-cost DNA synthesis, scale-up of industrial biotech platforms and the growing importance of the organism industry. As an added bonus, we have extended the conference to two full days this year, which means more networking opportunities and additional chances to connect with the growing community.

Who Should Attend?

  • Tech Practitioners: Hear about the latest technology, spot the upcoming trends, and meet the key people busily building the future.
  • Industry and Start-ups: Get critical opportunities to network, exhibit, and make the connections that you and your company need to grow.
  • Investors and Angels: Keep a finger on the pulse of technological development, and meet founders and investors as you hunt for your next unicorn.
  • Technology Scouts: Learn who the leading lights are in each segment, identify value-adding technologies, and lay the groundwork for further deals.
  • Academics:  Gain access to professionals ranging from eager potential cofounders to sagely experienced entrepreneurs and well-connected investors.
  • Students and Biohackers: Get yourself involved by meeting industry leaders and laying the groundwork for your community connections.

SynBioBeta SF 2016

Date & Location:

November 4, 2015 - November 6, 2015
8:00 am - 7:00 pm

Mission Bay Conference Center
Venue Information

See Who Spoke at SynBioBeta SF 2015

Testimonials

Emily Leproust

A conference not to be missed — this is the place for SynBio power users, experts, key opinion leaders, investors, vendors, students and novices.

Emily Leproust, CEO, Twist Bioscience

Lionel Clarke

SynBioBeta brings together many of the most innovative minds in the field of Synthetic Biology, sharing their enthusiasm and energy for turning ideas into reality.

Lionel Clarke, Co-Chair, UK Synthetic Biology Leadership Council

Tim Gardner

A Wonderful Opportunity For Synthetic Biology Entrepreneurs And Thinkers To Share Ideas, Network And Envision The Future.

Tim Gardner, CEO, Riffyn

Sponsors:

Platinum Sponsors:

Gold Sponsors:

Silver Sponsors:

Bronze Sponsors:

Featured Speakers:

Alicia Jackson


Alicia Jackson

DARPA

Catherine Coleman

Catherine Coleman
NASA

Christina Smolke

Christina Smolke
Antheia

Esther Dyson

Esther Dyson
HICCup

Jason Kelly

Jason Kelly
Ginkgo BioWorks

Randal Kirk

Randal Kirk
Intrexon

Rt. Hon. David Willetts

Rt. Hon. David Willetts
British Science Association

Sam Altman

Sam Altman
Y Combinator

Tim O’Reilly

Tim O’Reilly
O’Reilly Media

Speakers:

Adam D’Augelli

Adam D’Augelli
True Ventures

Alan Villalobos

Alan Villalobos
DNA2.0

Andrew Phillips

Andrew Phillips
Microsoft Research

Antony Evans

Antony Evans
TAXA

Arvind Gupta

Arvind Gupta
IndieBio

Benjamin Griffin

Benjamin Griffin
Synthetic Genomics

Carlo Quiñonez

Carlo Quiñonez
FATHOM

Catherine Barton

Catherine Barton
DuPont

Charles Fracchia

Charles Fracchia
BioBright

Christine Gould

Christine Gould
Syngenta

David McElroy

David McElroy
Ingenza

Eben Bayer

Eben Bayer
Ecovative

Elizabeth Iorns

Elizabeth Iorns
Science Exchange

Emily Leproust

Emily Leproust
Twist Bioscience

Hemai Parthasarathy

Hemai Parthasarathy
Breakout Labs

Ian Hanegraaff

Ian Hanegraaff
Analytik Jena

Ian Hanegraaff

Ian Hanegraaff
Analytik Jena

James Field

James Field
LabGenius

Jeffrey Hung

Jeffrey Hung
Vigene Biosciences

Jeffrey Kim

Jeffrey Kim
Radiant Genomics

Jeffrey Kim

Jeffrey Whitford
Sigma-Aldrich

Jenny Rooke

Jeffrey Whitford
Sigma-Aldrich

John Lesnick

John Lesnick
Labcyte

Jonathan Kotula

Jonathan Kotula
Synlogic

Josiah Zayner

Josiah Zayner
The ODIN

Joško Bobanović

Joško Bobanović
Sofinnova Partners

Kara Bortone

Joško Bobanović
Sofinnova Partners

Karl Handelsman

Karl Handelsman
Codon Capital

Kinkead Reiling

Kinkead Reiling
Angel Investor

Leigh Brody

Leigh Brody
Desktop Genetics

Marie Lee

Marie Lee
Transcriptic

Michael Fero

Michael Fero
TeselaGen

Michael Flanagan

Michael Flanagan
FlanaGen

Omri Amirav-Drory

Omri Amirav-Drory
Twist Bioscience

Patrick Westfall

Patrick Westfall
Zymergen

Paul Freemont

Paul Freemont
SynbiCITE

Randy Rettberg

Paul Freemont
SynbiCITE

Richard Kitney

Richard Kitney
SynbiCITE

Richard Yu

Paul Freemont
SynbiCITE

Robert Blazej

Robert Blazej
Novozymes

Sean Ward

Sean Ward
Synthace

Shaila Kotadia

Shaila Kotadia
Synberc

Soheila Vaezeslami

Soheila Vaezeslami
TTP Labtech

Stephen Chambers

Stephen Chambers
SynbiCITE

Stephen Laderman

Stephen Laderman
Agilent Technologies

Thomas Landrain

Thomas Landrain
PILI

Tim Fell

Tim Fell
Synthace

Tim Gardner

Tim Gardner
Riffyn

Tonya Jackson

Tonya Jackson
Sigma-Aldrich

Travis Bayer

Travis Bayer
Asilomar Bio

Vonnie Estes

Vonnie Estes
Consultant

Will Canine

Will Canine
OpenTrons

Yih-En Andrew Ban

Yih-En Andrew Ban
Arzeda

Advisory Committee:

Jenny Rooke

Jenny Rooke
5 Prime Ventures

John Cumbers

John Cumbers
SynBioBeta

Karl Sanford

Karl Sanford
DuPont

Richard Kitney

Richard Kitney
SynbiCITE

Thomas Landrain

Thomas Landrain
PILI

 

Zach Serber

Zach Serber
Zymergen

Zavain Dar

Zavain Dar
Lux Capital

Schedule:

Wednesday, Nov. 4th, 2015

Incubators and accelerators are playing an increasingly critical role in the synthetic biology ecosystem and are flourishing as a result. The holistic approach of these companies has helped countless startups become successful and, in turn, the number of biotech startups in their portfolios have grown. In this panel discussion we will be bringing together the synthetic biology accelerators and incubators who are providing seed funding, infrastructure and mentorship to support the growth of the industry.

  • Moderator: Lisa Krieger (San Jose Mercury News)
  • Speakers: Edward Amento (Molecular Medicine Research Institute), Kara Bortone (JLABS), Paul Freemont (SynbiCITE), Arvind Gupta (IndieBio), and Richard Yu (QB3@953)

Hear from the biodesigners, engineers and scientists who will share their cutting-edge research on biodesign. Learn about those making tools for designing biology along with insights relating to the creation of novel biomaterials out of renewable and sustainable sources. From fabrics and dyes, to packing materials, learn how these novel materials are being engineered without dependence on fossil fuels.

  • Moderator: Patrick Westfall, Zymergen
  • 10:05 am – 10:15 am: Omri Amirav-Drory, Genome Compiler
  • 10:15 am – 10:25 am: Eben Bayer, Ecovative
  • 10:25 am – 10:35 am: Michael Fero, TeselaGen
  • 10:35 am – 10:45 am: James Field, LabGenius
  • 10:45 am – 10:55 am: Thomas Landrain, PILI
  • 10:55 am – 11:05 am: Nigel Saunders, Brunel University
  • 11:05 am – 11:15 am: Derek Wells, DuPont

Keynote Speaker: Tim O’Reilly (O’Reilly Media)
This year’s Keynote at SynBioBeta will be given by the godfather of the open source software movement, founder and CEO of O’Reilly Media, Tim O’Reilly.  Tim’s keynote will cover the lessons he’s learned from open source communities that have fueled the growth of the internet and web and how these might be applied to biology.
After Tim’s keynote will be a panel discussion on “Open Source Lessons for Synthetic Biology” featuring panelists from two giants of the big ag industry: Kiersten Stead from Monsanto and Christine Gould from Syngenta, along with Jim Haseloff, the founder of OpenPlant, a new initiative promoting open technologies for plant synthetic biology.  The panel will be moderated by Roger Chen from OATV.

  • Moderator: Roger Chen (O’Reilly AlphaTech Ventures)
  • Speakers: Christine Gould (Syngenta), Jim Haseloff (OpenPlant, University of Cambridge), Tim O’Reilly (O’Reilly Media), Kiersten Stead (Monsanto Growth Ventures)

During the break take time to visit the exhibits, discuss with fellow SynBioBetans and enjoy the refreshments provided by our sponsors.
During this interactive investor panel you will get the chance to hear insightful discussions about various key updates and changes in synthetic biology as experiences are shared, with a particular focus on those funding companies based in the U.S. Discussions will include specific investment trends as well as valuable insight into where the industry is heading.

  • Moderator: Adam D’Augelli, (True Ventures)
  • Speakers: Dror Berman (Innovation Endeavors), Joško Bobanović (Sofinnova), Nan Li (Obvious Ventures), Matt Ocko (Data Collective), Jenny Rooke (5 Prime Ventures)

In this lightning talk session, we will hear from experienced companies and successful start-ups about novel products, thriving services, notable partnerships, funding updates and their insider analysis on current industry trends.

  • Moderator: Josiah Zayner, ODIN
  • 1:45 pm – 1:50 pm: Curt Becker, Molecular Assemblies
  • 1:50 pm – 1:55 pm: Rob Carlson, Bioeconomy Capital
  • 1:55 pm – 2:00 pm: Jeffrey Kim, Radiant Genomics
  • 2:00 pm – 2:05 pm: Shaila Kotadia, Synberc
  • 2:05 pm – 2:10 pm: Carlo Quiñonez, FATHOM
  • 2:10 pm – 2:15 pm: Soheila Vaezeslami, TTP Labtech

Gene editing has exploded in the last 12 months and rarely does a talk go by without some sort of CRISPR modification being mentioned. Our capabilities are allowing us to better engineer biology in order to create improved chemicals, drugs, foods, fuels and more via sustainable processes – something that was once thought to be impossible. In this session the practitioners of gene editing and metabolic engineering will dive into their latest discoveries and processes as they strive to make biology easier to engineer.

  • Moderator: Hemai Parthasarathy, Breakout Labs
  • 3:05 pm – 3:15 pm: Leigh Brody, Desktop Genetics
  • 3:15 pm – 3:25 pm: Adam Clore, Integrated DNA Technologies
  • 3:25 pm – 3:35 pm: Tommy Duncan, Touchlight Genetics
  • 3:35 pm – 3:45 pm: Benjamin Griffin, Synthetic Genomics
  • 3:45 pm – 3:55 pm: Jeffrey Hung, GenScript
  • 3:55 pm – 4:05 pm: Stephen Laderman, Agilent Technologies
  • 4:05 pm – 4:15 pm: Andrew May, Caribou Biosciences
  • 4:15 pm – 4:25 pm: Jason Potter, Thermo Fisher Scientific

Randal Kirk, CEO of Intrexon will be giving the second keynote at SynBioBeta SF. Learn about Intrexon, Kirk’s vision, the technology, the company story, and what the future holds.
Hear the latest from Twist CEO Emily Leproust, where she’ll give an update on the Alpha Access Program.
During the event guest host Esther Dyson, Founder of HICCup will introduce the top three contenders of the Blue Sky Bio Competition on stage, giving them each a chance to present to the crowd for a chance to win over $500 k in prizes. They will explain their big ideas, how they will use the prize resources, and why they should be voted #1. The audience will then vote live to decide the winners.

The Final 3 Candidates of the Blue Sky Bio Competition are:

  • Adam Freeman, CEO – alGas Biotech Inc.
  • David Johnson, Founder & CEO – GigaGen
  • Ewa Lis, Founder & CTO – Koliber Biosciences

Join us for a drink after an insightful day of talks! This welcome reception is hosted by Twist and is the perfect opportunity to keep the conversation going and mingle with your peers.

Thursday, Nov. 5th, 2015

Exciting recent advances in automation tools, including ubiquitous wireless connectivity and the internet of things, are allowing us to engineer biology more easily than ever before. These technologies are making our tools more autonomous and allowing them to better communicate with each other in order to complete protocols and accomplish experiments as designed. In this session we will be hearing from the cloud lab providers, the automatic liquid handler manufacturers, and other companies working to seamlessly connect these tools together. Join us for one of the most exciting topics of the conference!

  • Moderator: Ron Leuty, San Francisco Business Times
  • 9:10 am – 9:20 am: Will Canine, OpenTrons
  • 9:20 am – 9:30 am: Charles Fracchia, BioBright
  • 9:30 am – 9:40 am: Brian Frezza, Emerald Therapeutics
  • 9:40 am – 9:50 am: Tim Gardner, Riffyn
  • 9:50 am – 10:00 am: Ian Hanegraaff, Analytik Jena
  • 10:00 am – 10:10 am: Marie Lee, Transcriptic
  • 10:10 am – 10:20 am: Tim Fell, Synthace

In this lightning talk session, we will hear from experienced companies and successful start-ups about novel products, thriving services, notable partnerships, funding updates and their insider analysis on current industry trends.

  • Moderator: Vonnie Estes, Consultant
  • 11:10 am – 11:15 am: David Berube, North Carolina State University
  • 11:15 am – 11:20 am: Stephen Chambers, SynbiCITE
  • 11:20 am – 11:25 am: Antony Evans, TAXA
  • 11:25 am – 11:30 am: Michael Flanagan, FlanaGen
  • 11:30 am – 11:35 am: Jonathan Kotula, Synlogic
  • 11:35 am – 11:40 am: Devin Leake, Gen9
  • 11:40 am – 11:45 am: John Lesnick, Labcyte
  • 11:45 am – 11:50 am: Randy Rettberg, iGEM
  • 11:50 am – 11:55 am: Mary Ward, Counter Culture Labs

Wave one of Synthetic biology research and companies began more than a decade ago. Another wave of biology-astechnology research development and deployment, combining “Big Data” and the lessons of the last, is emerging today. Join Jay Keasling from the Joint BioEnergy Institute, and Kinkead Reiling, Angel Investor as they discuss their perspectives on the industry’s journey to today and what the future of biology may hold.
Enjoy lunch and take time to visit the exhibits, network, and enjoy the refreshments provided by our sponsors.
In this session, sponsored by the Sigma-Aldrich Green Chemistry Initiative, we will hear about all things green! Join us as we dive into how novel processes are being developed in biotechnology and synthetic biology, and learn how they are being used to create sustainable chemicals and additives that help reduce toxicity and current dependencies on fossil fuels.

  • Moderator: Tonya Jackson, Sigma-Aldrich
  • 1:30 pm – 1:40 pm: Travis Bayer, Asilomar Bio
  • 1:40 pm – 1:50 pm: Robert Blazej, Novozymes
  • 1:50 pm – 2:00 pm: Joel Cherry, Amyris
  • 2:00 pm – 2:10 pm: David McElroy, Ingenza
  • 2:10 pm – 2:20 pm: Ilan Wapinski, enEvolv
  • 2:20 pm – 2:30 pm: Jeffrey Whitford, Sigma-Aldrich

During the break take time to visit the exhibits, network with fellow peers and enjoy the refreshments. This break is sponsored by Zymergen.
In this session we will hear from the experts working to develop policies for synthetic biology, both US domestic and International. The panel will discuss the current and future strategies and policies needed in order to spread the responsible and sustainable adoption of biological technologies.

  • Moderator: Megan Palmer (Stanford University)
  • Speakers: Catherine Barton (DuPont), Lionel Clarke (UK Synthetic Biology Leadership Council), Todd Kuiken (Woodrow Wilson Center), Susan Rosser (University of Edinburgh)

In this fireside chat, Sam Altman, President of Y Combinator and Jason Kelly, CEO of Ginkgo Bioworks (the first synthetic biology company to be backed by Y Combinator) will discuss the year in synthetic biology. Topics will include Y Combinator’s new research lab, the move from apps to bio, and the role that synthetic biology will play in the future of engineering.
With our growing ability to collect increasingly large amounts of data from biological systems, comes the obligation to reliably store, analyze and manipulate this information. In this session we have assembled industry leading experts in big data and machine learning to explain the paramount roles of these technologies. They will discuss how technology today is allowing us to both understand and predict future trends that will iteratively feedback into experiment design.

  • Moderator: Andrew Phillips, Microsoft Research
  • 4:35 pm – 4:45 pm: Yih-En Andrew Ban, Arzeda
  • 4:45 pm – 4:55 pm: Ewa Lis, Koliber Biosciences
  • 4:55 pm – 5:05 pm: Alan Villalobos, DNA2.0

Join us for the last reception of the conference, hosted by UK Trade & Investment. The perfect opportunity to network and make connections before the end of the conference.
Wrap up the conference by attending the 1st Annual SynBioBeta Engineering Biology Awards and join us as we give special recognition to individuals that are making great strides to shape the synthetic biology industry. These individuals have helped establish the industry and played instrumental roles in providing infrastructure to support this new growing segment of the economy. Special guest host will be NASA Astronaut, Catherine Coleman.

  • Guest Host: Catherine Coleman (NASA)
  • This Year the SynBioBetas will be Awarded to:
    • Dr. Alicia Jackson, CTO at Drawbridge Health, & Former Deputy Director of the Biological Technologies Office at DARPA (introduced by Elizabeth Ions, Science Exchange)
    • Dr. Christina Smolke, Associate Professor at Stanford University & CEO of Antheia (Introduced by Karl Handelsman, Codon Capital)
    • The Rt Hon Lord David Willetts, Chair for the British Science Association and former British Science Minister (introduced by Richard Kitney, SynbiCITE)

Friday, Nov. 6th, 2015

Location: Pier 40, South Beach Harbor, San Francisco, CA
(North of AT&T Park, 1  1/2 Mile South of the Ferry Building)

You won’t want to miss our Networking Brunch Cruise on Friday, November 6th. Board the luxurious California Spirit at Pier 40 and enjoy a delicious brunch and networking in a casual atmosphere as we cruise along the bay, seeing some of San Francisco’s famous landmarks including The Bay Bridge and Alcatraz Island, cruising directly under the Golden Gate Bridge. Boarding will begin at 9:45 am so make sure to get there in time!

Partners: